Visit COVID-19 resources

[Skip to Content]

Vision UK Announce the chairs for two of their strategic transformational panels

Aug 30
2018

Vision UK have issued the following Press Release:  Vision UK are delighted to announce that the we have recruited joint chairs for both the Vision UK Research, Cures and Treatments panel and the Vision UK Services, Support and Care panel. Vision UK’s mission is to improve lives by raising the priority given to eye health

  • 30 August 2018

Incorrect IOL never events – an update

Aug 30
2018

NHS England fed back from their Never Event response meeting highlighting a recent occurrence in a UK ophthalmic unit: A patient was admitted to the hospital for cataract and ocular lens replacement. All WHO checks were completed prior to surgery as per protocol. An intraocular lens was chosen prior to start of surgery by surgeon

  • 30 August 2018

NOD Audit – Please check your data on your hospital EMR systems and in-house databases now – the next extraction date is 28 September

Aug 30
2018

The current round of the audit data collection ends on 31 August 2018. It is vital that you check the data on your Electronic Medical Record (EMR) systems and in-house databases to ensure accurate and complete data has been recorded before submission/extraction. The cataract audit data submission will take place on 28 September 2018 for

  • 30 August 2018

Save the date for our free NOD Audit quality improvement workshop – limited places

Aug 30
2018

The NOD team will be hosting free to attend Quality Improvement (QI) workshops for anyone participating or wishing to participate in the cataract audit. The workshops take place from 10.00am to 3.30pm on the following dates: Tuesday, 9 October 2018 at The Royal College of Ophthalmologists, London NW1 2HD Monday, 26 November 2018 at the

  • 30 August 2018

College advice on withdrawal of CyPass Micro-Stent by Alcon

Aug 30
2018

Alcon announced on 29 August 2018 the withdrawal of a glaucoma drainage device or micro-stent called ‘CyPass’ due to concerns about long term effects on the corneal endothelial cell count in their latest 5-year study. https://www.novartis.com/news/media-releases/alcon-announces-voluntary-global-market-withdrawal-cypass-micro-stent-surgical-glaucoma Whilst further guidance is expected from Alcon following consultation with the MHRA, the College is issuing the following advice

  • 30 August 2018